Supernus Pharmaceuticals (SUPN) Profit After Tax (2011 - 2026)
Supernus Pharmaceuticals (SUPN) recorded Profit After Tax of -$58.37 million in Q2 2026, compared with $22.5 million a year earlier.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Profit After Tax (2011 - 2026) Analysis & Trends
On a TTM basis, Supernus Pharmaceuticals' Profit After Tax came in at -$85.12 million as of Jun 30, 2026; for FY2025, it was -$38.55 million.
- Across earlier years, Profit After Tax came in at $73.87 million in FY2024, $1.32 million in FY2023 (-97.8%), $60.71 million in FY2022 (+13.6%) and $53.42 million in FY2021 (-57.9%).
- The Q2 2026 figure is the lowest quarterly Profit After Tax in data going back to Q1 2011.
- Peak year-over-year performance for Profit After Tax in the last five years was growth of 943.4% in Q4 2022, against a decline of 99.3% in Q1 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 5.28 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 3.09 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | -246.00 Mn |
| 10 | Supernus Pharmaceuticals | 2.45 Bn | 1.11 Bn | 185.39 Mn | -58.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -58.37 Mn |
| Dec 31, 2025 | -4.13 Mn |
| Sep 30, 2025 | -45.12 Mn |
| Jun 30, 2025 | 22.50 Mn |
| Mar 31, 2025 | -11.83 Mn |
| Dec 31, 2024 | 15.38 Mn |
| Sep 30, 2024 | 38.50 Mn |
| Jun 30, 2024 | 19.90 Mn |
| Mar 31, 2024 | 124,000.00 |
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | -16.01 Mn |
| Jun 30, 2023 | -827,000.00 |
| Mar 31, 2023 | 16.95 Mn |
| Dec 31, 2022 | 25.48 Mn |
| Sep 30, 2022 | 1.76 Mn |
| Jun 30, 2022 | 7.82 Mn |
| Mar 31, 2022 | 25.62 Mn |
| Dec 31, 2021 | 2.44 Mn |
| Sep 30, 2021 | 21.56 Mn |
| Jun 30, 2021 | 23.73 Mn |
API Access
Supernus Pharmaceuticals Profit After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();